首页> 外文OA文献 >Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

【2h】

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

机译：Lixisenatide每日疗效和安全性与丁肽每天两次在二甲双胍上不充分控制的2型糖尿病：24周，随机，开放标签，主动控制的研究（GetGoal-X）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
J. Rosenstock; D. Raccah; L. Koranyi; L. Maffei; G. Boka; P. Miossec; J. E. Gerich;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X). [J] . Julio Rosenstock, Denis Raccah, László Korányi, Diabetes care . 2013,第10期

机译：在二甲双胍控制不充分的2型糖尿病中，每天一次利西拉来和每日两次艾塞那肽的疗效和安全性：一项为期24周，随机，开放标签，主动对照的研究（GetGoal-X）。
2. Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [J] . Jabbour Serge A., Frias Juan P., Hardy Elise, Diabetes care . 2018,第10期

机译：Exenatide每周一次的安全性和疗效加上Dapagliflozin每日一度，并且单独服用exenatide或Dapagliflozin，患有2型糖尿病的患者与二甲双胍单疗法不充分控制：52周的持续时间-8随机对照试验
3. Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16-week, randomized, placebo-controlled trial [J] . Ross S., Thamer C., Cescutti J., Diabetes, obesity & metabolism . 2015,第7期

机译：依帕格列净治疗二甲双胍疗效不佳的2型糖尿病患者，每日两次疗效和安全性：一项为期16周，随机，安慰剂对照的研究
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin [O] . Julio Rosenstock, Denis Raccah, László Korányi, 2013

机译：在二甲双胍控制不充分的2型糖尿病中利西拉来每日一次与艾塞那肽每天两次的疗效和安全性
7. Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas [O] . Davies M., Heller S., Sreenan S., 2013

机译：每周一次Exenatide与每日一次或两次胰岛素Detemir：单独使用二甲双胍或与磺脲类药物联合治疗的2型糖尿病患者的疗效和安全性的随机，开放标签临床试验

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

著录项

相似文献

相关主题

期刊订阅